Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL is a chemical compound with the molecular formula C11H18N2O2. It is classified as a potential pharmaceutical agent, being listed in ZINC15, a database of compounds used in drug discovery. Additionally, it has been identified as a potential endocrine disrupting compound. While its chemical structure is defined, specific details regarding its development as a drug, primary indications, developers, manufacturers, or detailed mechanism of action as a therapeutic agent are not readily available in public databases. It is noted to have chemical-target interactions according to DrugBank and the Therapeutic Target Database (TTD), suggesting potential biological activity, but the specific targets and functional effects are not specified.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 4-(2,5-DIAMINO-5-HYDROXY-PENTYL)-PHENOL.